Literature DB >> 8122861

[Anticoagulant treatment and pregnancy. Apropos of 47 cases].

F Lecuru1, R Taurelle, M Desnos.   

Abstract

The authors report a series of 47 patients treated with anticoagulants during pregnancy. The commonest indication was the presence of an artificial heart valve (72.3% of cases), most often mitral (58.9%). Thirty seven women were treated with heparin (group I) and ten with oral anticoagulants (OA) (group II) during the first three months. There was one peripheral venous thrombotic event and 2 post-partum deaths. Obstetric complications were equally distributed between the 2 groups, with the exception of spontaneous abortions during the first three months and fetal deaths, which were commoner with OA. Hemorrhagic complications occurred in 17% of cases at the time of delivery and during the immediate post-partum period. One case of coumarin embryopathy was seen. This series confirms that three periods are dangerous in the context of anticoagulant treatment during pregnancy: the first three months, delivery and postpartum. We recommend the use of heparin during the first three months and at the end of pregnancy, restricting OA to the period between 4 and 9 months.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8122861

Source DB:  PubMed          Journal:  Ann Cardiol Angeiol (Paris)        ISSN: 0003-3928


  1 in total

1.  Outcome of pregnancy in women with mechanical valves.

Authors:  Z A Ashour; H A Shawky; M Hassan Hussein
Journal:  Tex Heart Inst J       Date:  2000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.